These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19758415)

  • 1. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review.
    Kolahi J; Bang H; Park J
    Community Dent Oral Epidemiol; 2009 Dec; 37(6):477-84. PubMed ID: 19758415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial.
    Houweling AH; Shapiro S; Cohen JM; Kahn SR
    Clin Trials; 2014 Oct; 11(5):547-52. PubMed ID: 24902921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of blinding in randomized controlled trials found results inconsistent and questionable.
    Boutron I; Estellat C; Ravaud P
    J Clin Epidemiol; 2005 Dec; 58(12):1220-6. PubMed ID: 16291465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
    Miller LE; Stewart ME
    Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
    Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
    Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010.
    Baethge C; Assall OP; Baldessarini RJ
    Psychother Psychosom; 2013; 82(3):152-60. PubMed ID: 23548796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
    Fergusson D; Glass KC; Waring D; Shapiro S
    BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of the success of blinding in antidepressant RCTs.
    Scott AJ; Sharpe L; Colagiuri B
    Psychiatry Res; 2022 Jan; 307():114297. PubMed ID: 34861421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Blind Leading the Not-So-Blind: A Meta-Analysis of Blinding in Pharmacological Trials for Chronic Pain.
    Colagiuri B; Sharpe L; Scott A
    J Pain; 2019 May; 20(5):489-500. PubMed ID: 30248448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing blinding in randomised controlled trials of acupuncture: challenges and recommendations.
    Hopton AK; Macpherson H
    Chin J Integr Med; 2011 Mar; 17(3):173-6. PubMed ID: 21359917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reporting of blinding in orthodontic randomized controlled trials: where do we stand?
    Abdulraheem S; Bondemark L
    Eur J Orthod; 2019 Jan; 41(1):54-58. PubMed ID: 29697755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Approach to Assess Blinding for Transcranial Direct Current Stimulation Treatment in Patients with Fibromyalgia. A Randomized Clinical Trial.
    Arroyo-Fernández R; Avendaño-Coy J; Velasco-Velasco R; Palomo-Carrión R; Bravo-Esteban E; Ferri-Morales A
    Brain Sci; 2021 Oct; 11(10):. PubMed ID: 34679399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deliberate ignorance: a systematic review of blinding in nursing clinical trials.
    Polit DF; Gillespie BM; Griffin R
    Nurs Res; 2011; 60(1):9-16. PubMed ID: 21127453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the dark: the reporting of blinding status in randomized controlled trials.
    Montori VM; Bhandari M; Devereaux PJ; Manns BJ; Ghali WA; Guyatt GH
    J Clin Epidemiol; 2002 Aug; 55(8):787-90. PubMed ID: 12384193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintaining the blind in sham controlled interventional trials: lessons from the EPISOD study.
    Cotton P; Pauls Q; Wood A; Durkalski-Mauldin V
    Endosc Int Open; 2019 Nov; 7(11):E1322-E1326. PubMed ID: 31673601
    [No Abstract]   [Full Text] [Related]  

  • 17. Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory.
    Hróbjartsson A; Pildal J; Chan AW; Haahr MT; Altman DG; Gøtzsche PC
    J Clin Epidemiol; 2009 Sep; 62(9):967-73. PubMed ID: 19635403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blinding of an acupuncture randomized controlled trial optimized with clinical translational science award resources.
    Steffen AD; Burke LA; Pauls HA; Suarez ML; Yao Y; Kobak WH; Takayama M; Yajima H; Kaptchuk TJ; Takakura N; Wilkie DJ; Schlaeger JM
    Clin Trials; 2020 Oct; 17(5):545-551. PubMed ID: 32650673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinding in randomised trials: hiding who got what.
    Schulz KF; Grimes DA
    Lancet; 2002 Feb; 359(9307):696-700. PubMed ID: 11879884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blinding in randomized clinical trials: imposed impartiality.
    Hróbjartsson A; Boutron I
    Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.